Abstract | BACKGROUND: STUDY DESIGN: Nested case-control. SETTING & PARTICIPANTS: 100 cases of incident CKD stage 3 and 100 age-and sex-matched controls in the Framingham Heart Study; 141 cases and 135 age-, sex-, and race-matched controls in the Atherosclerosis Risk in Communities (ARIC) Study. Controls had eGFR ≥60 mL/min/1.73 m(2) at follow-up in both studies. PREDICTORS: Urinary CTGF concentrations. OUTCOMES: Incident CKD stage 3, defined as eGFR <60 mL/min/1.73 m(2). MEASUREMENTS: Stored urine samples from Framingham Heart Study and ARIC were measured for CTGF. Covariates were obtained from Framingham Heart Study and ARIC participant examinations. RESULTS: In the Framingham Heart Study, the median baseline urinary CTGF concentration was lower in cases (1.35 ng/mL) than controls (2.35 ng/mL; paired t test, P < 0.0001). The multivariable-adjusted OR for incident CKD stage 3 was 0.33 (95% CI, 0.17-0.64; P < 0.001) per 1-standard deviation in log urinary CTGF level after adjustment for CKD risk factors, baseline eGFR, and baseline log urinary albumin- creatinine ratio, with similar results in participants without diabetes (n = 184). Results were not materially different when urinary CTGF level was indexed to urinary creatinine level (multivariable-adjusted OR, 0.34; 95% CI, 0.21-0.56; P < 0.001). A similar, but nonsignificant, trend of risk of incident CKD stage 3 with lower baseline urinary CTGF concentration was observed in an independent case-control study conducted in the ARIC Study, with the strongest results observed in participants free of diabetes. This inverse relationship was robust in meta-analysis of both the overall and diabetes-free groups. LIMITATIONS: Observational study; causality cannot be inferred. CONCLUSIONS: Lower urinary CTGF concentrations precede the onset of CKD stage 3 in the general population. Further work is required to fully characterize how CTGF level influences risk of CKD.
|
Authors | Conall M O'Seaghdha, Shih-Jen Hwang, Nrupen A Bhavsar, Anna Köttgen, Josef Coresh, Brad C Astor, Caroline S Fox |
Journal | American journal of kidney diseases : the official journal of the National Kidney Foundation
(Am J Kidney Dis)
Vol. 57
Issue 6
Pg. 841-9
(Jun 2011)
ISSN: 1523-6838 [Electronic] United States |
PMID | 21292366
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
|
Copyright | Published by Elsevier Inc. |
Chemical References |
- Biomarkers
- CCN2 protein, human
- Connective Tissue Growth Factor
|
Topics |
- Biomarkers
(urine)
- Connective Tissue Growth Factor
(urine)
- Disease Progression
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Humans
- Incidence
- Kidney Failure, Chronic
(epidemiology, urine)
- Male
- Middle Aged
- Nephelometry and Turbidimetry
- Population Surveillance
- Prognosis
- Prospective Studies
- Severity of Illness Index
- United States
(epidemiology)
|